This approach was used to conduct molecular analysis of LDLR in 50 patients with heterozygous FH, facilitating detection of 21 potentially disease-causing mutations in 23 patients (46%), excluding several frequent polymorphisms. The gene discussed is LDLR; the disease is familial hyperaldosteronism.